Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Roots Analysis | PRODUCT CODE: 1066060

Cover Image

PUBLISHER: Roots Analysis | PRODUCT CODE: 1066060

Pharmaceutical Secondary Packaging Market by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5899
PDF (Site License)
USD 7999
PDF (Department License)
USD 10599
PDF (Enterprise License)
USD 17999

Add to Cart

Title:
Pharmaceutical Secondary Packaging
Market by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and RoW): Industry Trends and Global Forecasts, 2022-2035.

Example Insights:

Overview:

On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. Further, studies indicate that more than 100,000 tons of pharmaceutical products are consumed globally per year. In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and secondary packaging solutions. Specifically, pharmaceutical secondary packaging is a vital step in the product supply chain as it encloses life-saving drugs and therapies, preserving the identity, quality, integrity and stability of the packaged drug product. It also plays a key role in marketing and brand projection for a product. However, the process of secondary packaging usually involves time consuming and complex activities, such as blister carding, thermoforming, labeling, kitting, assembly and cold chain storage (for temperature sensitive biologics). Other key challenges faced by developers are limiting variability in packaging materials and ensuring compliance to stringent regulatory guidelines (for packaging designs). Considering the aforementioned concerns, many pharmaceutical players now prefer to collaborate with qualified packaging providers that offer non-traditional packaging solutions and have the required capabilities to create unique packaging designs, in a cost and time effective manner.

As per the CDMO Outsourcing Survey conducted by Nice Insight, specifically for clinical and commercial scale operations, nearly 60% of the pharmaceutical companies currently outsource their primary packaging needs, while 43% of the players outsource their secondary packaging requirements. At present, more than 160 companies offer secondary packaging solutions to the firms engaged in the pharmaceutical sector. Further, several recent advancements in packaging designs, technologies and materials have enabled service providers to offer a wide range of user-friendly pharmaceutical secondary packaging solutions. In addition, substantial expansions, mergers and acquisitions, and partnerships have been reported in this market as service providers strive to become one-stop-shops, in order to cater to the diverse needs of their clients engaged in the healthcare industry. Driven by the ongoing innovation in this field, continuous growth in the pharmaceutical drugs pipeline and a steady rise in drug approvals, the pharmaceutical secondary packaging market is likely to witness positive growth in the foreseen future.

Scope of the Report:

The 'Pharmaceutical Secondary Packaging Market - Distribution by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035' report features an extensive study of the current market landscape and future potential of the pharmaceutical secondary packaging market. The study features an in-depth analysis, highlighting the capabilities of pharmaceutical secondary packaging providers. Amongst other elements, the report features:

  • A detailed overview of the overall landscape of companies offering secondary packaging solutions to the pharmaceutical and biotechnology industries, along with information on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and rest of the world) and scale of operation (preclinical, clinical and commercial). The chapter also covers details related to the type of service provider (one-stop-shop service providers and stand-alone service providers), type of secondary packaging offered (cartons, boxes and others), type of primary packaging packed (blisters, vials, bottles, conventional syringes, ampoules, prefilled syringes and others), type of molecule packed (biologics, small molecules and unspecified), type of finished dosage form packed (solids, liquids / injectables, semi-solids, powders and others) and type of additional service(s) offered (labeling, serialization, kitting and cold-chain storage).
  • An insightful competitiveness analysis of the pharmaceutical secondary packaging providers, based on supplier power (in terms of years of experience), company competitiveness (type secondary packaging offered, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, and type of additional services offered) and their respective scale of operation.
  • An analysis of recent partnerships inked between stakeholders engaged in this domain, during the period 2018-2021, covering acquisitions, manufacturing and packaging agreements, service alliances, packaging agreements, distribution agreements, technology utilization agreements and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership, type of molecule packed, type of finished dosage form packed and most active players (in terms of number of partnerships). It also highlights the regional distribution of the partnership activity witnessed in this market.
  • A detailed analysis of the recent expansions undertaken by various pharmaceutical secondary packaging providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansion, facility expansion and new facility), scale of operation, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, company size, location of headquarters, location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution (region-wise and country-wise).
  • An in-depth analysis to estimate the current and future demand for pharmaceutical secondary packaging, based on several relevant parameters, such as type of secondary packaging (boxes, cartons and pouches), type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world), for the period 2022-2035.
  • Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in offering pharmaceutical secondary packaging solutions, across North America, Europe and Asia-Pacific. Each profile provides an overview of the company, featuring information on the year of establishment, number of employees, location of their headquarters, key executives, details related to its secondary packaging offerings, recent developments, and an informed future outlook

One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the pharmaceutical secondary packaging market, over the coming 13 years. We have provided an informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.

The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:

  • Jake Aspinall (Commercial Director, Active Pharma Supplies)
  • Silvio Del Deo (Managing Director, Depo Pack)
  • Joe Luke (Vice President, Sales and Marketing, Reed-Lane)

Key Questions Answered:

  • Who are the leading players engaged in the pharmaceutical secondary packaging domain?
  • What is the relative competitiveness of different pharmaceutical secondary packaging providers?
  • Which type of partnership models are most commonly adopted by industry stakeholders?
  • What kind of expansion initiatives have been undertaken by pharmaceutical secondary packaging providers?
  • What is the present and likely future demand for secondary packaging solutions in the pharmaceutical sector?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Chapter Outlines:

Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the pharmaceutical secondary packaging market in the short to mid-term, and long term.

Chapter 3 provides a general overview of pharmaceutical packaging and importance / need for packaging in the pharmaceutical industry. Further, it contains a brief introduction to pharmaceutical secondary packaging, different types of pharmaceutical secondary packaging solutions and importance of secondary packaging in the pharmaceutical industry. The chapter concludes with a discussion on the key opportunity areas for secondary packaging providers and inputs on their projected growth in the coming years.

Chapter 4 features a detailed review of the current market landscape of around 165 companies offering pharmaceutical secondary packaging services. Additionally, it features an in-depth analysis of service providers, based on a number of relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters and scale of operation (preclinical, clinical and commercial). Further, the chapter also covers details about type of service provider (one-stop-shop service providers and stand-alone service providers), type of secondary packaging offered (cartons, boxes and others), type of primary packaging packed (blisters, vials, bottles, conventional syringes, ampoules, prefilled syringes and others), type of molecule packed (biologics, small molecules and unspecified), type of finished dosage form packed (solids, liquids / injectables, semi-solids, powders and others) and type of additional services offered (labeling, serialization, kitting and cold-chain storage).

Chapter 5 presents an insightful competitiveness analysis of the pharmaceutical secondary packaging providers, located in North America, Europe, and Asia-Pacific and rest of the world. The companies are further segmented based on their employee count, into three categories, namely small (1-200 employees), mid-sized (201-500 employees) and large (>500 employees) across these geographies. The analysis compares the service providers on the basis of various parameters, such as supplier power (in terms of years of experience), company competitiveness (type secondary packaging offered, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, and type of additional services offered) and scale of operation (preclinical, clinical and commercial).

Chapter 6 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in North America. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.

Chapter 7 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in Europe. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.

Chapter 8 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in Asia-Pacific. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.

Chapter 9 features an insightful analysis of the various partnerships and collaborations that have been inked by stakeholders engaged in this domain (since 2018). It includes a brief description of the partnership models (including acquisitions, manufacturing and packaging agreements, service alliances, packaging agreements, distribution agreements, technology utilization agreements and others) adopted by stakeholders in the domain of pharmaceutical secondary packaging. Further, it comprises of analysis based on several relevant parameters such as year of agreement, type of agreement, type of molecule packed, type of finished dosage form packed and most active players (in terms of number of partnerships). Further, the chapter includes a world map representation of all the deals inked in this field in the period 2018-2021, highlighting both intercontinental and intracontinental partnership activity.

Chapter 10 presents a detailed analysis of the recent expansions undertaken (since 2018) by various pharmaceutical secondary packaging providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansion, facility expansion and new facility), scale of operation (preclinical, clinical and commercial), type of primary packaging packed (blisters, bottles, syringes, vials, ampoules, sachets), type of molecule packed (biologics and small molecules), type of finished dosage form packed (solids and liquids), company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and rest of the world), location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution (region-wise and country-wise).

Chapter 11 includes an in-depth analysis in order to estimate the current and future demand for pharmaceutical secondary packaging, based on several relevant parameters, such as type of secondary packaging (boxes, cartons and pouches), type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world), for the period 2022-2035.

Chapter 12 presents an insightful market forecast analysis, highlighting the likely growth of the pharmaceutical secondary packaging market, for the period 2022-2035. Additionally, the report features the likely distribution of the current and forecasted opportunity across various relevant parameters such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world).

Chapter 13 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 provides the transcripts of the interviews conducted with representatives from renowned organizations that are engaged in providing pharmaceutical secondary packaging. The chapter contains the details of our conversation with Jake Aspinall (Commercial Director, Active Pharma Supplies), Silvio Del Deo (Managing Director, Depo Pack) and Joe Luke (Vice President, Sales and Marketing, Reed-Lane).

Chapter 15 is an appendix, that provides tabulated data and numbers for all the figures included in the report.

Chapter 16 is an appendix that provides the list of companies and organizations that have been mentioned in the report.

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Pharmaceutical Packaging
    • 3.2.1. Key Attributes of Pharmaceutical Packaging
    • 3.2.2. Types of Pharmaceutical Packaging
  • 3.3. Introduction to Pharmaceutical Secondary Packaging
    • 3.3.1 Types of Secondary Packaging Used in the Pharmaceutical Industry
    • 3.3.2 Importance / Need for Secondary Packaging
  • 3.4. Concluding Remarks

4. COMPETITIVE LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Pharmaceutical Secondary Packaging Providers: Overall Market Landscape
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Scale of Operation
    • 4.2.5. Analysis by Type of Service Provider
    • 4.2.6. Analysis by Type of Secondary Packaging Offered
    • 4.2.7. Analysis by Type of Primary Packaging Packed
    • 4.2.8. Analysis by Type of Molecule Packed
    • 4.2.9. Analysis by Type of Finished Dosage Form Packed
    • 4.2.10. Analysis by Types of Additional Services Offered

5. COMPANY COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Assumptions and Key Parameters
  • 5.3. Methodology
  • 5.4. Company Competitiveness Analysis: Pharmaceutical Secondary Packaging Providers
    • 5.4.1. Pharmaceutical Secondary Packaging Providers in North America
      • 5.4.1.1. Competitiveness Analysis: Small Companies in North America
      • 5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
      • 5.4.1.3. Competitiveness Analysis: Large Companies in North America
    • 5.4.2. Pharmaceutical Secondary Packaging Providers in Europe
      • 5.4.2.1. Competitiveness Analysis: Small Companies in Europe
      • 5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
      • 5.4.2.3. Competitiveness Analysis: Large Companies in Europe
    • 5.4.3. Pharmaceutical Secondary Packaging Providers in Asia-Pacific and Rest of the World
      • 5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
      • 5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
      • 5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World

6. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN NORTH AMERICA

  • 6.1. Chapter Overview
  • 6.2. Catalent
    • 6.2.1. Company Overview
    • 6.2.2. Pharmaceutical Secondary Packaging Offerings
    • 6.2.3. Recent Developments and Future Outlook
  • 6.3. Patheon (By Thermo Fisher Scientific)
    • 6.3.1. Company Overview
    • 6.3.2. Pharmaceutical Secondary Packaging Offerings
    • 6.3.3. Recent Developments and Future Outlook
  • 6.4. PCI Pharma Services
    • 6.4.1. Company Overview
    • 6.4.2. Pharmaceutical Secondary Packaging Offerings
    • 6.4.3. Recent Developments and Future Outlook
  • 6.5. Pfizer CentreOne
    • 6.5.1. Company Overview
    • 6.5.2. Pharmaceutical Secondary Packaging Offerings
    • 6.5.3. Recent Developments and Future Outlook
  • 6.6. Sharp
    • 6.6.1. Company Overview
    • 6.6.2. Pharmaceutical Secondary Packaging Offerings
    • 6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN EUROPE

  • 7.1. Chapter Overview
  • 7.2. Almac Group
    • 7.2.1. Company Overview
    • 7.2.2. Pharmaceutical Secondary Packaging Offerings
    • 7.2.3. Recent Developments and Future Outlook
  • 7.3. Central Pharma
    • 7.3.1. Company Overview
    • 7.3.2. Pharmaceutical Secondary Packaging Offerings
    • 7.3.3. Recent Developments and Future Outlook
  • 7.4. CordenPharma
    • 7.4.1. Company Overview
    • 7.4.2. Pharmaceutical Secondary Packaging Offerings
    • 7.4.3. Recent Developments and Future Outlook
  • 7.5. Eurofins CDMO
    • 7.5.1. Company Overview
    • 7.5.2. Pharmaceutical Secondary Packaging Offerings
    • 7.5.3. Recent Developments and Future Outlook
  • 7.6. Tjoapack
    • 7.6.1. Company Overview
    • 7.6.2. Pharmaceutical Secondary Packaging Offerings
    • 7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN ASIA-PACIFIC

  • 8.1. Chapter Overview
  • 8.2. ABS (Australian Blister Sealing)
    • 8.2.1. Company Overview
    • 8.2.2. Pharmaceutical Secondary Packaging Offerings
    • 8.2.3. Recent Developments and Future Outlook
  • 8.3. Bushu Pharma
    • 8.3.1. Company Overview
    • 8.3.2. Pharmaceutical Secondary Packaging Offerings
    • 8.3.3. Recent Developments and Future Outlook
  • 8.4. CMIC
    • 8.4.1. Company Overview
    • 8.4.2. Pharmaceutical Secondary Packaging Offerings
    • 8.4.3. Recent Developments and Future Outlook
  • 8.5. Kishore group
    • 8.5.1. Company Overview
    • 8.5.2. Pharmaceutical Secondary Packaging Offerings
    • 8.5.3. Recent Developments and Future Outlook
  • 8.6. Prince Art Packages
    • 8.6.1. Company Overview
    • 8.6.2. Pharmaceutical Secondary Packaging Offerings
    • 8.6.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Pharmaceutical Secondary Packaging Providers: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Type of Molecule Packed
    • 9.3.5. Analysis by Type of Finished Dosage Form Packed
    • 9.3.6. Most Active Players: Analysis by Number of Partnerships
    • 9.3.7. Geographical Analysis
      • 9.3.7.1. Intercontinental and Intracontinental Deals
      • 9.3.8.2. International and Local Deals

10. RECENT EXPANSIONS

  • 10.1. Chapter Overview
  • 10.2. Pharmaceutical Secondary Packaging Providers: Recent Expansions
    • 10.2.1. Analysis by Year of Expansion
    • 10.2.2. Analysis by Type of Expansion
    • 10.2.3. Analysis by Scale of Operation
    • 10.2.4. Analysis by Type of Expansion and Scale of Operation
    • 10.2.5. Analysis by Type of Primary Packaging Packed
    • 10.2.6. Analysis by Type of Molecule Packed
    • 10.2.7. Analysis by Type of Expansion and Type of Molecule Packed
    • 10.2.8. Analysis by Type of Finished Dosage Form Packed
    • 10.2.9. Analysis by Company Size and Location of Headquarters
    • 10.2.10. Analysis by Location of Expanded Facility
    • 10.2.11. Analysis by Type of Expansion and Location of Expanded Facility
    • 10.2.12. Most Active Players: Analysis by Number of Recent Expansions
    • 10.2.13. Geographical Analysis
      • 10.2.13.1. Region-wise Distribution
      • 10.2.13.2. Country-wise Distribution

11. DEMAND ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Key Assumptions and Methodology
  • 11.3. Global Demand for Pharmaceutical Secondary Packaging, 2022-2035
    • 11.3.1. Analysis by Type of Secondary Packaging
      • 11.3.1.1. Global Demand for Pharmaceutical Secondary Packaging Boxes, 2022-2035
      • 11.3.1.2. Global Demand for Pharmaceutical Secondary Packaging Cartons, 2022-2035
      • 11.3.1.3. Global Demand for Pharmaceutical Secondary Packaging Pouches, 2022-2035
    • 11.3.2. Analysis by Type of Primary Packaging Packed
      • 11.3.2.1. Global Demand for Ampoules, 2022-2035
      • 11.3.2.2. Global Demand for Blister Packs, 2022-2035
      • 11.3.2.3. Global Demand for Bottles, 2022-2035
      • 11.3.2.4. Global Demand for Cartridges, 2022-2035
      • 11.3.2.5. Global Demand for Syringes, 2022-2035
      • 11.3.2.6. Global Demand for Vials, 2022-2035
    • 11.3.3. Analysis by Geography
      • 11.3.3.1. Demand for Pharmaceutical Secondary Packaging in North America, 2022-2035
        • 11.3.3.1.1. Demand for Pharmaceutical Secondary Packaging Boxes in North America, 2022-2035
        • 11.3.3.1.2. Demand for Pharmaceutical Secondary Packaging Cartons in North America, 2022-2035
        • 11.3.3.1.3. Demand for Pharmaceutical Secondary Packaging Pouches in North America, 2022-2035
      • 11.3.3.2. Demand for Pharmaceutical Secondary Packaging in Europe, 2022-2035
        • 11.3.3.2.1. Demand for Pharmaceutical Secondary Packaging Boxes in Europe, 2022-2035
        • 11.3.3.2.2. Demand for Pharmaceutical Secondary Packaging Cartons in Europe, 2022-2035
        • 11.3.3.3.3. Demand for Pharmaceutical Secondary Packaging Pouches in Europe, 2022-2035
      • 11.3.3.3. Demand for Pharmaceutical Secondary Packaging in Asia-Pacific, 2022-2035
        • 11.3.3.3.1. Demand for Pharmaceutical Secondary Packaging Boxes in Asia-Pacific, 2022-2035
        • 11.3.3.3.2. Demand for Pharmaceutical Secondary Packaging Cartons in Asia-Pacific, 2022-2035
        • 11.3.3.3.3. Demand for Pharmaceutical Secondary Packaging Pouches in Asia-Pacific, 2022-2035
      • 11.3.3.4. Demand for Pharmaceutical Secondary Packaging in MENA, 2022-2035
        • 11.3.3.4.1. Demand for Pharmaceutical Secondary Packaging Boxes in MENA, 2022-2035
        • 11.3.3.4.2. Demand for Pharmaceutical Secondary Packaging Cartons in MENA, 2022-2035
        • 11.3.3.4.3. Demand for Pharmaceutical Secondary Packaging Pouches in MENA, 2022-2035
      • 11.3.3.5. Demand for Pharmaceutical Secondary Packaging in Latin America, 2022-2035
        • 11.3.3.5.1. Demand for Pharmaceutical Secondary Packaging Boxes in Latin America, 2022-2035
        • 11.3.3.5.2. Demand for Pharmaceutical Secondary Packaging Cartons in Latin America, 2022-2035
        • 11.3.3.5.3. Demand for Pharmaceutical Secondary Packaging Pouches in Latin America, 2022-2035
      • 11.3.3.6. Demand for Pharmaceutical Secondary Packaging in Rest of the World, 2022-2035
        • 11.3.3.6.1. Demand for Pharmaceutical Secondary Packaging Boxes in Rest of the World, 2022-2035
        • 11.3.3.6.2. Demand for Pharmaceutical Secondary Packaging Cartons in Rest of the World, 2022-2035
        • 11.3.3.6.3. Demand for Pharmaceutical Secondary Packaging Pouches in Rest of the World, 2022-2035

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Forecast Methodology
  • 12.3. Global Pharmaceutical Secondary Packaging Market, 2022-2035
    • 12.3.1. Pharmaceutical Secondary Packaging Market: Distribution by Type of Secondary Packaging, 2022 and 2035
      • 12.3.1.1. Pharmaceutical Secondary Packaging Market for Boxes, 2022-2035
      • 12.3.1.2. Pharmaceutical Secondary Packaging Market for Cartons, 2022-2035
      • 12.3.1.3. Pharmaceutical Secondary Packaging Market for Pouches, 2022-2035
    • 12.3.2. Pharmaceutical Secondary Packaging Market: Distribution by Type of Primary Packaging Packed, 2022 and 2035
      • 12.3.2.1. Pharmaceutical Secondary Packaging Market for Ampoules, 2022-2035
      • 12.3.2.2. Pharmaceutical Secondary Packaging Market for Blister Packs, 2022-2035
      • 12.3.2.3. Pharmaceutical Secondary Packaging Market for Bottles, 2022-2035
      • 12.3.2.4. Pharmaceutical Secondary Packaging Market for Cartridges, 2022-2035
      • 12.3.2.5. Pharmaceutical Secondary Packaging Market for Syringes, 2022-2035
      • 12.3.2.6. Pharmaceutical Secondary Packaging Market for Vials, 2022-2035
    • 12.3.3. Pharmaceutical Secondary Packaging Market: Distribution by Geography, 2022-2035
      • 12.3.3.1. Pharmaceutical Secondary Packaging Market in North America, 2022 and 2035
        • 12.3.3.1.1. Pharmaceutical Secondary Packaging Market for Boxes in North America, 2022-2035
        • 12.3.3.1.2. Pharmaceutical Secondary Packaging Market for Cartons in North America, 2022-2035
        • 12.3.3.1.3. Pharmaceutical Secondary Packaging Market for Pouches, in North America, 2022-2035
      • 12.3.3.2. Pharmaceutical Secondary Packaging Market in Europe, 2022 and 2035
        • 12.3.3.2.1. Pharmaceutical Secondary Packaging Market for Boxes in Europe, 2022-2035
        • 12.3.3.2.2. Pharmaceutical Secondary Packaging Market for Cartons in Europe, 2022-2035
        • 12.3.3.2.3. Pharmaceutical Secondary Packaging Market for Pouches in Europe, 2022-2035
      • 12.3.3.3. Pharmaceutical Secondary Packaging Market in Asia-Pacific, 2022 and 2035
        • 12.3.3.3.1. Pharmaceutical Secondary Packaging Market for Boxes in Asia-Pacific, 2022-2035
        • 12.3.3.3.2. Pharmaceutical Secondary Packaging Market for Cartons in Asia-Pacific, 2022-2035
        • 12.3.3.3.3. Pharmaceutical Secondary Packaging Market for Pouches in Asia-Pacific, 2022-2035
      • 12.3.3.4. Pharmaceutical Secondary Packaging Market in MENA, 2022 and 2035
        • 12.3.3.4.1. Pharmaceutical Secondary Packaging Market for Boxes in MENA, 2022-2035
        • 12.3.3.4.2. Pharmaceutical Secondary Packaging Market for Cartons in MENA, 2022-2035
        • 12.3.3.4.3. Pharmaceutical Secondary Packaging Market for Pouches in MENA, 2022-2035
      • 12.3.3.5. Pharmaceutical Secondary Packaging Market in Latin America, 2022 and 2035
        • 12.3.3.5.1. Pharmaceutical Secondary Packaging Market for Boxes in Latin America, 2022-2035
        • 12.3.3.5.2. Pharmaceutical Secondary Packaging Market for Cartons in Latin America, 2022-2035
        • 12.3.3.5.3. Pharmaceutical Secondary Packaging Market for Pouches in Latin America, 2022-2035
      • 12.3.3.6. Pharmaceutical Secondary Packaging Market in Rest of the World, 2022 and 2035
        • 12.3.3.6.1. Pharmaceutical Secondary Packaging Market for Boxes in Rest of the World, 2022-2035
        • 12.3.3.6.2. Pharmaceutical Secondary Packaging Market for Cartons in Rest of the World, 2022-2035
        • 12.3.3.6.3. Pharmaceutical Secondary Packaging Market for Pouches in Rest of the World, 2022-2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

  • 14.1. Chapter Overview
  • 14.2. Active Pharma Supplies
    • 14.2.1. Company Snapshot
    • 14.2.2. Interview Transcript: Jake Aspinall, Commercial Director
  • 14.3. Depo Pack
    • 14.3.1. Company Snapshot
    • 14.3.2. Interview Transcript: Silvio Del Deo, Managing Director
  • 14.4. Reed-Lane
    • 14.4.1. Company Snapshot
    • 14.4.2. Interview Transcript: Joe Luke, Vice President, Sales and Marketing

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

  • Figure 2.1 Executive Summary: Overall Market Landscape
  • Figure 2.2 Executive Summary: Partnerships and Collaborations
  • Figure 2.3 Executive Summary: Recent Expansions
  • Figure 2.4 Executive Summary: Demand Analysis
  • Figure 2.5 Executive Summary: Market Forecast
  • Figure 3.1 Key Advantages of Pharmaceutical Packaging
  • Figure 3.2 Key Attributes of Pharmaceutical Packaging
  • Figure 3.3 Type of Pharmaceutical Packaging
  • Figure 3.4 Type of Packaging Products
  • Figure 3.5 Various Contents of Packaging Materials
  • Figure 4.1 Pharmaceutical Secondary Packaging Providers: Distribution by Year of Establishment
  • Figure 4.2 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size
  • Figure 4.3 Pharmaceutical Secondary Packaging Providers: Distribution by Location of
  • Figure 4.4 Pharmaceutical Secondary Packaging Providers: Distribution by Location of Headquarters (Country-wise)
  • Figure 4.5 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size and Location of Headquarters
  • Figure 4.6 Pharmaceutical Secondary Packaging Providers: Distribution by Scale of Operation
  • Figure 4.7 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Service Provider
  • Figure 4.8 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Secondary Packaging Offered
  • Figure 4.9 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Primary Packaging Packed
  • Figure 4.10 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Molecule Packed
  • Figure 4.11 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Finished Dosage Form Packed
  • Figure 4.12 Pharmaceutical Secondary Packaging Providers: Distribution by Types of Additional Services Offered
  • Figure 5.1 Company Competitiveness Analysis: Small Companies in North America
  • Figure 5.2 Company Competitiveness Analysis: Mid-sized Companies in North America
  • Figure 5.3 Company Competitiveness Analysis: Large Companies in North America
  • Figure 5.4 Company Competitiveness Analysis: Small Companies in Europe
  • Figure 5.5 Company Competitiveness Analysis: Mid-sized Companies in Europe
  • Figure 5.6 Company Competitiveness Analysis: Large Companies in Europe
  • Figure 5.7 Company Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
  • Figure 5.8 Company Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
  • Figure 5.9 Company Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World
  • Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership, 2018-2019 and 2020-2021
  • Figure 9.5 Partnerships and Collaborations: Distribution by Type of Molecule Packed
  • Figure 9.6 Partnerships and Collaborations: Distribution by Type of Finished Dosage Form Packed
  • Figure 9.7 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.8 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Figure 9.9 Partnerships and Collaborations: Distribution of International and Local Deals
  • Figure 10.1 Recent Expansions: Cumulative Year-wise Trend, 2018-2022
  • Figure 10.2 Recent Expansions: Distribution by Type of Expansion
  • Figure 10.3 Recent Expansions: Distribution by Scale of Operation
  • Figure 10.4 Recent Expansions: Distribution by Type of Expansion and Scale of Operation
  • Figure 10.5 Recent Expansions: Distribution by Type of Primary Packaging Packed
  • Figure 10.6 Recent Expansions: Distribution by Type of Molecule Packed
  • Figure 10.7 Recent Expansions: Distribution by Type of Expansion and Type of Molecule Packed
  • Figure 10.8 Recent Expansions: Distribution by Type of Finished Dosage Form Packed
  • Figure 10.9 Recent Expansions: Distribution by Company Size and Location of Headquarters
  • Figure 10.10 Recent Expansions: Distribution by Location of Expanded Facility
  • Figure 10.11 Recent Expansions: Distribution by Type of Expansion and Location of Expanded Facility
  • Figure 10.12 Most Active Players: Distribution by Number of Recent Expansions
  • Figure 10.13 Recent Expansions: Year-wise Trend by Geography, 2018-2022
  • Figure 10.14 Recent Expansions: Country-wise Distribution
  • Figure 11.1 Global Demand for Pharmaceutical Secondary Packaging, 2022-2035 (Billion Units)
  • Figure 11.2 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Secondary Packaging, 2022-2035 (Billion Units)
  • Figure 11.3 Global Demand for Pharmaceutical Secondary Packaging Boxes, 2022-2035 (Billion Units)
  • Figure 11.4 Global Demand for Pharmaceutical Secondary Packaging Cartons, 2022-2035 (Billion Units)
  • Figure 11.5 Global Demand for Pharmaceutical Secondary Packaging Pouches, 2022-2035 (Billion Units)
  • Figure 11.6 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (Billion Units)
  • Figure 11.7 Demand for Pharmaceutical Secondary Packaging of Ampoules, 2022-2035 (Billion Units)
  • Figure 11.8 Demand for Pharmaceutical Secondary Packaging of Blister Packs, 2022-2035 (Billion Units)
  • Figure 11.9 Demand for Pharmaceutical Secondary Packaging of Bottles, 2022-2035 (Billion Units)
  • Figure 11.10 Demand for Pharmaceutical Secondary Packaging of Cartridges, 2022-2035 (Billion Units)
  • Figure 11.11 Demand for Pharmaceutical Secondary Packaging of Syringes, 2022-2035 (Billion Units)
  • Figure 11.12 Demand for Pharmaceutical Secondary Packaging of Vials, 2022-2035 (Billion Units)
  • Figure 11.13 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Geography, 2022 and 2035 (Billion Units)
  • Figure 11.14 Demand for Pharmaceutical Secondary Packaging in North America, 2022-2035 (Billion Units)
  • Figure 11.15 Demand for Pharmaceutical Secondary Packaging Boxes in North America, 2022-2035 (Billion Units)
  • Figure 11.16 Demand for Pharmaceutical Secondary Packaging Cartons in North America, 2022-2035 (Billion Units)
  • Figure 11.17 Demand for Pharmaceutical Secondary Packaging Pouches in North America, 2022-2035 (Billion Units)
  • Figure 11.18 Demand for Pharmaceutical Secondary Packaging in Europe, 2022-2035 (Billion Units)
  • Figure 11.19 Demand for Pharmaceutical Secondary Packaging Boxes in Europe, 2022-2035 (Billion Units)
  • Figure 11.20 Demand for Pharmaceutical Secondary Packaging Cartons in Europe, 2022-2035 (Billion Units)
  • Figure 11.21 Demand for Pharmaceutical Secondary Packaging Pouches in Europe, 2022-2035 (Billion Units)
  • Figure 11.22 Demand for Pharmaceutical Secondary Packaging in Asia-Pacific, 2022-2035 (Billion Units)
  • Figure 11.23 Demand for Pharmaceutical Secondary Packaging Boxes in Asia-Pacific, 2022-2035 (Billion Units)
  • Figure 11.24 Demand for Pharmaceutical Secondary Packaging Cartons in Asia-Pacific, 2022-2035 (Billion Units)
  • Figure 11.25 Demand for Pharmaceutical Secondary Packaging Pouches in Asia-Pacific, 2022-2035 (Billion Units)
  • Figure 11.26 Demand for Pharmaceutical Secondary Packaging in MENA, 2022-2035 (Billion Units)
  • Figure 11.27 Demand for Pharmaceutical Secondary Packaging Boxes in MENA, 2022-2035 (Billion Units)
  • Figure 11.28 Demand for Pharmaceutical Secondary Packaging Cartons in MENA, 2022-2035 (Billion Units)
  • Figure 11.29 Demand for Pharmaceutical Secondary Packaging Pouches in MENA, 2022-2035 (Million Units)
  • Figure 11.30 Demand for Pharmaceutical Secondary Packaging in Latin America, 2022-2035 (Billion Units)
  • Figure 11.31 Demand for Pharmaceutical Secondary Packaging Boxes in Latin America, 2022-2035 (Billion Units)
  • Figure 11.32 Demand for Pharmaceutical Secondary Packaging Cartons in Latin America, 2022-2035 (Billion Units)
  • Figure 11.33 Demand for Pharmaceutical Secondary Packaging Pouches in Latin America, 2022-2035 (Million Units)
  • Figure 11.34 Demand for Pharmaceutical Secondary Packaging in Rest of the World, 2022-2035 (Billion Units)
  • Figure 11.35 Demand for Pharmaceutical Secondary Packaging Boxes in Rest of the World, 2022-2035 (Billion Units)
  • Figure 11.36 Demand for Pharmaceutical Secondary Packaging Cartons in Rest of the World, 2022-2035 (Billion Units)
  • Figure 11.37 Demand for Pharmaceutical Secondary Packaging Pouches in Rest of the World, 2022-2035 (Million Units)
  • Figure 12.1 Global Pharmaceutical Secondary Packaging Market, 2022-2035 (USD Billion)
  • Figure 12.2 Pharmaceutical Secondary Packaging Market: Distribution by Type of Secondary Packaging, 2022 and 2035 (USD Billion)
  • Figure 12.3 Global Pharmaceutical Secondary Packaging Market for Boxes, 2022-2035 (USD Billion)
  • Figure 12.4 Global Pharmaceutical Secondary Packaging Market for Cartons, 2022-2035 (USD Billion)
  • Figure 12.5 Global Pharmaceutical Secondary Packaging Market for Pouches, 2022-2035 (USD Billion)
  • Figure 12.6 Pharmaceutical Secondary Packaging Market: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (USD Billion)
  • Figure 12.7 Pharmaceutical Secondary Packaging Market for Ampoules, 2022-2035 (USD Billion)
  • Figure 12.8 Pharmaceutical Secondary Packaging Market for Blister Packs, 2022-2035 (USD Billion)
  • Figure 12.9 Pharmaceutical Secondary Packaging Market for Bottles, 2022-2035 (USD Billion)
  • Figure 12.10 Pharmaceutical Secondary Packaging Market for Cartridges, 2022-2035 (USD Billion)
  • Figure 12.11 Pharmaceutical Secondary Packaging Market for Syringes, 2022-2035 (USD Billion)
  • Figure 12.12 Pharmaceutical Secondary Packaging Market for Vials, 2022-2035 (USD Billion)
  • Figure 12.13 Pharmaceutical Secondary Packaging Market: Distribution by Geography, 2022 and 2035 (USD Billion)
  • Figure 12.14 Pharmaceutical Secondary Packaging Market in North America, 2022 and 2035 (USD Billion)
  • Figure 12.15 Pharmaceutical Secondary Packaging Market for Boxes in North America, 2022-2035 (USD Billion)
  • Figure 12.16 Pharmaceutical Secondary Packaging Market for Cartons in North America, 2022-2035 (USD Billion)
  • Figure 12.17 Pharmaceutical Secondary Packaging Market for Pouches in North America, 2022-2035 (USD Billion)
  • Figure 12.18 Pharmaceutical Secondary Packaging Market in Europe, 2022 and 2035 (USD Billion)
  • Figure 12.19 Pharmaceutical Secondary Packaging Market for Boxes in Europe, 2022-2035 (USD Billion)
  • Figure 12.20 Pharmaceutical Secondary Packaging Market for Cartons in Europe, 2022-2035 (USD Billion)
  • Figure 12.21 Pharmaceutical Secondary Packaging Market for Pouches in Europe, 2022-2035 (USD Billion)
  • Figure 12.22 Pharmaceutical Secondary Packaging Market in Asia-Pacific, 2022 and 2035 (USD Billion)
  • Figure 12.23 Pharmaceutical Secondary Packaging Market for Boxes in Asia-Pacific, 2022-2035 (USD Billion)
  • Figure 12.24 Pharmaceutical Secondary Packaging Market for Cartons in Asia-Pacific, 2022-2035 (USD Billion)
  • Figure 12.25 Pharmaceutical Secondary Packaging Market for Pouches in Asia-Pacific, 2022-2035 (USD Billion)
  • Figure 12.26 Pharmaceutical Secondary Packaging Market in MENA, 2022 and 2035 (USD Billion)
  • Figure 12.27 Pharmaceutical Secondary Packaging Market for Boxes in MENA, 2022-2035 (USD Billion)
  • Figure 12.28 Pharmaceutical Secondary Packaging Market for Cartons in MENA, 2022-2035 (USD Billion)
  • Figure 12.29 Pharmaceutical Secondary Packaging Market for Pouches in MENA, 2022-2035 (USD Billion)
  • Figure 12.30 Pharmaceutical Secondary Packaging Market in Latin America, 2022 and 2035 (USD Billion)
  • Figure 12.31 Pharmaceutical Secondary Packaging Market for Boxes in Latin America, 2022-2035 (USD Billion)
  • Figure 12.32 Pharmaceutical Secondary Packaging Market for Cartons in Latin America, 2022-2035 (USD Billion)
  • Figure 12.33 Pharmaceutical Secondary Packaging Market for Pouches in Latin America, 2022-2035 (USD Billion)
  • Figure 12.34 Pharmaceutical Secondary Packaging Market in Rest of the World, 2022 and 2035 (USD Billion)
  • Figure 12.35 Pharmaceutical Secondary Packaging Market for Boxes in Rest of the World, 2022-2035 (USD Billion)
  • Figure 12.36 Pharmaceutical Secondary Packaging Market for Cartons in Rest of the World, 2022-2035 (USD Billion)
  • Figure 12.37 Pharmaceutical Secondary Packaging Market for Pouches in Rest of the World, 2022-2035 (USD Billion)
  • Figure 13.1 Concluding Remarks: Overall Market Landscape
  • Figure 13.2 Concluding Remarks: Partnerships and Collaborations
  • Figure 13.3 Concluding Remarks: Recent Expansions
  • Figure 13.4 Concluding Remarks: Demand Analysis
  • Figure 13.5 Concluding Remarks: Market Forecast

List Of Tables

  • Table 4.1 List of Pharmaceutical Secondary Packaging Providers
  • Table 4.2 Pharmaceutical Secondary Packaging Providers: Information on Type of Secondary Packaging Offered
  • Table 4.3 Pharmaceutical Secondary Packaging Providers: Information on Types of Additional Service Offered
  • Table 6.1 Leading Pharmaceutical Secondary Packaging Service Providers in North America
  • Table 6.2 Catalent: Company Snapshot
  • Table 6.3 Catalent: Pharmaceutical Secondary Packaging Offerings
  • Table 6.4 Catalent: Recent Developments and Future Outlook
  • Table 6.5 Patheon: Company Snapshot
  • Table 6.6 Patheon: Pharmaceutical Secondary Packaging Offerings
  • Table 6.7 Patheon: Recent Developments and Future Outlook
  • Table 6.8 PCI Pharma Services: Company Snapshot
  • Table 6.9 PCI Pharma Services: Pharmaceutical Secondary Packaging Offerings
  • Table 6.10 PCI Pharma Services: Recent Developments and Future Outlook
  • Table 6.11 Pfizer CentreOne: Company Snapshot
  • Table 6.12 Pfizer CentreOne: Pharmaceutical Secondary Packaging Offerings
  • Table 6.13 Pfizer CentreOne: Recent Developments and Future Outlook
  • Table 6.14 Sharp: Company Snapshot
  • Table 6.15 Sharp: Pharmaceutical Secondary Packaging Offerings
  • Table 6.16 Sharp: Recent Developments and Future Outlook
  • Table 7.1 Leading Pharmaceutical Secondary Packaging Service Providers in Europe
  • Table 7.2 Almac Group: Company Snapshot
  • Table 7.3 Almac Group: Pharmaceutical Secondary Packaging Offerings
  • Table 7.4 Almac Group: Recent Developments and Future Outlook
  • Table 7.5 Central Pharma: Company Snapshot
  • Table 7.6 Central Pharma: Pharmaceutical Secondary Packaging Offerings
  • Table 7.7 Central Pharma: Recent Developments and Future Outlook
  • Table 7.8 CordenPharma: Company Snapshot
  • Table 7.9 CordenPharma: Pharmaceutical Secondary Packaging Offerings
  • Table 7.10 CordenPharma: Recent Developments and Future Outlook
  • Table 7.11 Eurofins CDMO: Company Snapshot
  • Table 7.12 Eurofins CDMO: Pharmaceutical Secondary Packaging Offerings
  • Table 7.13 Eurofins CDMO: Recent Developments and Future Outlook
  • Table 7.14 Tjoapack: Company Snapshot
  • Table 7.15 Tjoapack: Pharmaceutical Secondary Packaging Offerings
  • Table 7.16 Tjoapack: Recent Developments and Future Outlook
  • Table 8.1 Leading Pharmaceutical Secondary Packaging Service Providers in Asia-Pacific
  • Table 8.2 ABS: Company Snapshot
  • Table 8.3 ABS: Pharmaceutical Secondary Packaging Offerings
  • Table 8.4 ABS: Recent Developments and Future Outlook
  • Table 8.5 Bushu Pharma: Company Snapshot
  • Table 8.6 Bushu Pharma: Pharmaceutical Secondary Packaging Offerings
  • Table 8.7 Bushu Pharma: Recent Developments and Future Outlook
  • Table 8.8 CMIC: Company Snapshot
  • Table 8.9 CMIC: Pharmaceutical Secondary Packaging Offerings
  • Table 8.10 CMIC: Recent Developments and Future Outlook
  • Table 8.11 Kishore Group: Company Snapshot
  • Table 8.12 Kishore Group: Pharmaceutical Secondary Packaging Offerings
  • Table 8.13 Kishore Group: Recent Developments and Future Outlook
  • Table 8.14 Prince Art Packages: Company Snapshot
  • Table 8.15 Prince Art Packages: Pharmaceutical Secondary Packaging Offerings
  • Table 8.16 Prince Art Packages: Recent Developments and Future Outlook
  • Table 9.1 Pharmaceutical Secondary Packaging Providers: List of Partnerships and Collaborations, 2018-2021
  • Table 10.1 Pharmaceutical Secondary Packaging Providers: Recent Expansions, 2018-2022
  • Table 15.1 Pharmaceutical Secondary Packaging Providers: Distribution by Year of Establishment
  • Table 15.2 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size
  • Table 15.3 Pharmaceutical Secondary Packaging Providers: Distribution by Location of
  • Table 15.4 Pharmaceutical Secondary Packaging Providers: Distribution by Location of Headquarters (Country-wise)
  • Table 15.5 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size and Location of Headquarters
  • Table 15.6 Pharmaceutical Secondary Packaging Providers: Distribution by Scale of Operation
  • Table 15.7 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Service Provider
  • Table 15.8 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Secondary Packaging Offered
  • Table 15.9 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Primary Packaging Packed
  • Table 15.10 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Molecule Packed
  • Table 15.11 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Finished Dosage Form Packed
  • Table 15.12 Pharmaceutical Secondary Packaging Providers: Distribution by Types of Additional Services Offered
  • Table 15.13 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
  • Table 15.14 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 15.15 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 15.16 Partnerships and Collaborations: Distribution by Type of Partnership, 2018-2019 and 2020-2021
  • Table 15.17 Partnerships and Collaborations: Distribution by Type of Molecule Packed
  • Table 15.18 Partnerships and Collaborations: Distribution by Type of Finished Dosage Form Packed
  • Table 15.19 Most Active Players: Distribution by Number of Partnerships
  • Table 15.20 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Table 15.21 Partnerships and Collaborations: Distribution of International and Local Deals
  • Table 15.22 Recent Expansions: Cumulative Year-wise Trend, 2018-2022
  • Table 15.23 Recent Expansions: Distribution by Type of Expansion
  • Table 15.24 Recent Expansions: Distribution by Scale of Operation
  • Table 15.25 Recent Expansions: Distribution by Type of Expansion and Scale of Operation
  • Table 15.26 Recent Expansions: Distribution by Type of Primary Packaging Packed
  • Table 15.27 Recent Expansions: Distribution by Type of Molecule Packed
  • Table 15.28 Recent Expansions: Distribution by Type of Expansion and Type of Molecule Packed
  • Table 15.29 Recent Expansions: Distribution by Type of Finished Dosage Form Packed
  • Table 15.30 Recent Expansions: Distribution by Company Size and Location of Headquarters
  • Table 15.31 Recent Expansions: Distribution by Location of Expanded Facility
  • Table 15.32 Recent Expansions: Distribution by Type of Expansion and Location of Expanded Facility
  • Table 15.33 Most Active Players: Distribution by Number of Recent Expansions
  • Table 15.34 Recent Expansions: Year-wise Trend by Geography, 2018-2022
  • Table 15.35 Recent Expansions: Country-wise Distribution
  • Table 15.36 Global Demand for Pharmaceutical Secondary Packaging, 2022-2035 (Billion Units)
  • Table 15.37 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Secondary Packaging, 2022-2035 (Billion Units)
  • Table 15.38 Global Demand for Pharmaceutical Secondary Packaging Boxes, 2022-2035 (Billion Units)
  • Table 15.39 Global Demand for Pharmaceutical Secondary Packaging Cartons, 2022-2035 (Billion Units)
  • Table 15.40 Global Demand for Pharmaceutical Secondary Packaging Pouches, 2022-2035 (Billion Units)
  • Table 15.41 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (Billion Units)
  • Table 15.42 Demand for Pharmaceutical Secondary Packaging of Ampoules, 2022-2035 (Billion Units)
  • Table 15.43 Demand for Pharmaceutical Secondary Packaging of Blister Packs, 2022-2035 (Billion Units)
  • Table 15.44 Demand for Pharmaceutical Secondary Packaging of Bottles, 2022-2035 (Billion Units)
  • Table 15.45 Demand for Pharmaceutical Secondary Packaging of Cartridges, 2022-2035 (Billion Units)
  • Table 15.46 Demand for Pharmaceutical Secondary Packaging of Syringes, 2022-2035 (Billion Units)
  • Table 15.47 Demand for Pharmaceutical Secondary Packaging of Vials, 2022-2035 (Billion Units)
  • Table 15.48 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Geography, 2022 and 2035 (Billion Units)
  • Table 15.49 Demand for Pharmaceutical Secondary Packaging in North America, 2022-2035 (Billion Units)
  • Table 15.50 Demand for Pharmaceutical Secondary Packaging Boxes in North America, 2022-2035 (Billion Units)
  • Table 15.51 Demand for Pharmaceutical Secondary Packaging Cartons in North America, 2022-2035 (Billion Units)
  • Table 15.52 Demand for Pharmaceutical Secondary Packaging Pouches in North America, 2022-2035 (Billion Units)
  • Table 15.53 Demand for Pharmaceutical Secondary Packaging in Europe, 2022-2035 (Billion Units)
  • Table 15.54 Demand for Pharmaceutical Secondary Packaging Boxes in Europe, 2022-2035 (Billion Units)
  • Table 15.55 Demand for Pharmaceutical Secondary Packaging Cartons in Europe, 2022-2035 (Billion Units)
  • Table 15.56 Demand for Pharmaceutical Secondary Packaging Pouches in Europe, 2022-2035 (Billion Units)
  • Table 15.57 Demand for Pharmaceutical Secondary Packaging in Asia-Pacific, 2022-2035 (Billion Units)
  • Table 15.58 Demand for Pharmaceutical Secondary Packaging Boxes in Asia-Pacific, 2022-2035 (Billion Units)
  • Table 15.59 Demand for Pharmaceutical Secondary Packaging Cartons in Asia-Pacific, 2022-2035 (Billion Units)
  • Table 15.60 Demand for Pharmaceutical Secondary Packaging Pouches in Asia-Pacific, 2022-2035 (Billion Units)
  • Table 15.61 Demand for Pharmaceutical Secondary Packaging in MENA, 2022-2035 (Billion Units)
  • Table 15.62 Demand for Pharmaceutical Secondary Packaging Boxes in MENA, 2022-2035 (Billion Units)
  • Table 15.63 Demand for Pharmaceutical Secondary Packaging Cartons in MENA, 2022-2035 (Billion Units)
  • Table 15.64 Demand for Pharmaceutical Secondary Packaging Pouches in MENA, 2022-2035 (Million Units)
  • Table 15.65 Demand for Pharmaceutical Secondary Packaging in Latin America, 2022-2035 (Billion Units)
  • Table 15.66 Demand for Pharmaceutical Secondary Packaging Boxes in Latin America, 2022-2035 (Billion Units)
  • Table 15.67 Demand for Pharmaceutical Secondary Packaging Cartons in Latin America, 2022-2035 (Billion Units)
  • Table 15.68 Demand for Pharmaceutical Secondary Packaging Pouches in Latin America, 2022-2035 (Million Units)
  • Table 15.69 Demand for Pharmaceutical Secondary Packaging in Rest of the World, 2022-2035 (Billion Units)
  • Table 15.70 Demand for Pharmaceutical Secondary Packaging Boxes in Rest of the World, 2022-2035 (Billion Units)
  • Table 15.71 Demand for Pharmaceutical Secondary Packaging Cartons in Rest of the World, 2022-2035 (Billion Units)
  • Table 15.72 Demand for Pharmaceutical Secondary Packaging Pouches in Rest of the World, 2022-2035 (Million Units)
  • Table 15.73 Global Pharmaceutical Secondary Packaging Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.74 Pharmaceutical Secondary Packaging Market: Distribution by Type of Secondary Packaging, 2022 and 2035 (USD Billion)
  • Table 15.75 Global Pharmaceutical Secondary Packaging Market for Boxes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.76 Global Pharmaceutical Secondary Packaging Market for Cartons, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.77 Global Pharmaceutical Secondary Packaging Market for Pouches, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.78 Pharmaceutical Secondary Packaging Market: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (USD Billion)
  • Table 15.79 Pharmaceutical Secondary Packaging Market for Ampoules, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.80 Pharmaceutical Secondary Packaging Market for Blister Packs, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.81 Pharmaceutical Secondary Packaging Market for Bottles, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.82 Pharmaceutical Secondary Packaging Market for Cartridges, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.83 Pharmaceutical Secondary Packaging Market for Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.84 Pharmaceutical Secondary Packaging Market for Vials, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.85 Pharmaceutical Secondary Packaging Market: Distribution by Geography, 2022 and 2035 (USD Billion)
  • Table 15.86 Pharmaceutical Secondary Packaging Market in North America, 2022 and 2035 (USD Billion)
  • Table 15.87 Pharmaceutical Secondary Packaging Market for Boxes in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.88 Pharmaceutical Secondary Packaging Market for Cartons in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.89 Pharmaceutical Secondary Packaging Market for Pouches in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.90 Pharmaceutical Secondary Packaging Market in Europe, 2022 and 2035 (USD Billion)
  • Table 15.91 Pharmaceutical Secondary Packaging Market for Boxes in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.92 Pharmaceutical Secondary Packaging Market for Cartons in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.93 Pharmaceutical Secondary Packaging Market for Pouches in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.94 Pharmaceutical Secondary Packaging Market in Asia-Pacific, 2022 and 2035 (USD Billion)
  • Table 15.95 Pharmaceutical Secondary Packaging Market for Boxes in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.96 Pharmaceutical Secondary Packaging Market for Cartons in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.97 Pharmaceutical Secondary Packaging Market for Pouches in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.98 Pharmaceutical Secondary Packaging Market in MENA, 2022 and 2035 (USD Billion)
  • Table 15.99 Pharmaceutical Secondary Packaging Market for Boxes in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.100 Pharmaceutical Secondary Packaging Market for Cartons in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.101 Pharmaceutical Secondary Packaging Market for Pouches in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.102 Pharmaceutical Secondary Packaging Market in Latin America, 2022 and 2035 (USD Billion)
  • Table 15.103 Pharmaceutical Secondary Packaging Market for Boxes in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.104 Pharmaceutical Secondary Packaging Market for Cartons in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.105 Pharmaceutical Secondary Packaging Market for Pouches in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.106 Pharmaceutical Secondary Packaging Market in Rest of the World, 2022 and 2035 (USD Billion)
  • Table 15.107 Pharmaceutical Secondary Packaging Market for Boxes in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.108 Pharmaceutical Secondary Packaging Market for Cartons in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
  • Table 15.109 Pharmaceutical Secondary Packaging Market for Pouches in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 1. 3C! Packaging
  • 2. 3R Pharmaceutical Industries
  • 3. ABS (Australian Blister Sealing)
  • 4. Acceleration Laboratory Services
  • 5. Acorda Therapeutics
  • 6. Active Pharma Supplies
  • 7. Aenova
  • 8. Alcami
  • 9. Alcura
  • 10. Alifarm Laboratories
  • 11. allpack group
  • 12. Almac Group
  • 13. Alnylam Pharmaceuticals
  • 14. Amcor
  • 15. Amgen
  • 16. Ansapack
  • 17. Anthos Therapeutics
  • 18. Aphena Pharma Solutions
  • 19. Aquapak
  • 20. AR Packaging
  • 21. Ardena
  • 22. Arkay Packaging
  • 23. AstraZeneca
  • 24. Atecna
  • 25. Aucta Pharmaceuticals
  • 26. Autajon
  • 27. BAP Pharma
  • 28. Bellwyck
  • 29. Bellwyck Pharma Services (acquired by PCI Pharma Services)
  • 30. Bemis
  • 31. Berkshire Sterile Manufacturing
  • 32. Berlin Packaging
  • 33. Berry Global
  • 34. Biotechnica (acquired by Central Pharma)
  • 35. Birchwood Contract Manufacturing
  • 36. Bormioli Pharma
  • 37. Bristol-Myers Squibb
  • 38. Bushu Pharma
  • 39. Caligor Coghlan Pharma Services
  • 40. Cannasupplies
  • 41. Capsugel
  • 42. Cardinal Health
  • 43. Carton Service
  • 44. Catalent
  • 45. CCL Healthcare
  • 46. CellBios
  • 47. Central Pharma
  • 48. CIT
  • 49. CleanCut Technologies (acquired by Oliver Healthcare Packaging)
  • 50. CMIC Group
  • 51. Cobra Biologics
  • 52. Constantia Flexibles
  • 53. Content Group
  • 54. CordenPharma
  • 55. CoreRx
  • 56. Corplex
  • 57. Coveris
  • 58. CREAPHARM
  • 59. CRNA Pharma
  • 60. CRYOPDP
  • 61. Cryoport Systems
  • 62. CWS Contract Packaging
  • 63. Dec Group
  • 64. Depo Pack
  • 65. Dr. Müller Pharma
  • 66. DS Smith
  • 67. Dunamis Packaging
  • 68. East Pharma Technologies
  • 69. Ecobliss
  • 70. elpack
  • 71. Endeavour Foundation
  • 72. Essentra Packaging
  • 73. Eumedica
  • 74. Eurofins CDMO
  • 75. EVERSANA
  • 76. Experic
  • 77. Faller Packaging
  • 78. Falorni Pharma
  • 79. Fermion (subsidiary of Orion)
  • 80. FIDELIO Healthcare
  • 81. First Wave BioPharma
  • 82. Firstan Holdings (acquired by AR Packaging)
  • 83. G&W Laboratories
  • 84. GCL Pharma
  • 85. GHO Capital
  • 86. Global Pharma CM
  • 87. good natured
  • 88. Graphic Packaging International
  • 89. HENNIG ARZNEIMITTEL
  • 90. HERMES PHARMA
  • 91. Honeywood (acquired by Wasdell Group)
  • 92. Howell Packaging
  • 93. Hughes Enterprises
  • 94. Huhtamaki
  • 95. IMP Pharmaceutical Services
  • 96. Inno4Life (acquired by Dec Group)
  • 97. Innova Medical Group
  • 98. Intrapak
  • 99. IRISYS (acquired by Recro)
  • 100. Janssen
  • 101. Jones Healthcare Group
  • 102. K+D (acquired by AR Packaging)
  • 103. Kansas City Design (acquired by Oliver Healthcare Packaging)
  • 104. KapStone (acquired by WestRock)
  • 105. Kerry Pharma
  • 106. Keystone Folding Box
  • 107. KFM Co-Packer
  • 108. KISHORE GROUP
  • 109. Klocke Group
  • 110. Klocke of America
  • 111. Konsyl Pharmaceuticals
  • 112. Körber Pharma
  • 113. Koru Pacific Packaging
  • 114. Kroha (acquired by AR packaging)
  • 115. Kymanox
  • 116. Leca Graphics
  • 117. Legacy Pharma Solutions
  • 118. Linkx Packaging Systems (acquired by WestRock)
  • 119. Lonza
  • 120. LSNE Contract Manufacturing
  • 121. Lutz Packaging
  • 122. Mak Pharma
  • 123. Manufacture Générale de Joints (MGJ)
  • 124. McKesson RxPak
  • 125. MED PACK
  • 126. Med-X-Press
  • 127. Mikart (acquired by Nautic Partners)
  • 128. Mission Pharmacal
  • 129. MM Packaging
  • 130. Moderna
  • 131. Mondi Group
  • 132. Morgen Pharmaceutical Services (MPhS)
  • 133. Nautic Partners
  • 134. Nedupack Thermoforming
  • 135. Network Partners
  • 136. NUVISAN
  • 137. Oliver Healthcare Packaging
  • 138. Omaks Printing and Packaging
  • 139. oncomed
  • 140. Origin Pharma Packaging
  • 141. Orlando-Equity
  • 142. Orofino Pharmaceuticals
  • 143. PACS International
  • 144. Palladio Group
  • 145. Pangraph
  • 146. PaperFoam
  • 147. Paperpack
  • 148. Paras Printpack
  • 149. Parle Global Technologies
  • 150. Patheon (Thermo Fischer Scientific)
  • 151. PCI Pharma Services
  • 152. Pelican BioThermal
  • 153. Pemcor Packaging
  • 154. Performance Systematix (acquired by Selig Group)
  • 155. Pfizer CentreOne
  • 156. Pharma Packaging Solutions (acquired by Tjoapack)
  • 157. Pharma Print (acquired by Faller Packaging)
  • 158. Pharmaceutical Contractors
  • 159. Pharmaceutical Packaging Professionals (acquired by PCI Pharma Services)
  • 160. Pharmaserv Logistics
  • 161. Pharmasol
  • 162. Pharmeco
  • 163. Phathom Pharmaceuticals
  • 164. Photocure
  • 165. Piramal Pharma Solutions
  • 166. PKG Packaging
  • 167. Planned Packaging Films (acquired by Wasdell Group)
  • 168. Plymouth Packaging (acquired by WestRock)
  • 169. Praxis Packaging Solutions
  • 170. Prespack
  • 171. Prince Art Packages
  • 172. Qualiskills
  • 173. Quality Chemicals
  • 174. Quality Packaging Specialists International (QPSI)
  • 175. Quinta-Analytica
  • 176. Recipharm
  • 177. Recro
  • 178. Reed-Lane
  • 179. RENOLIT Healthcare
  • 180. REPASSA
  • 181. rlc Packaging Group (acquired by AR Packaging)
  • 182. Rondo-Pak
  • 183. Ropack Pharma Solutions
  • 184. Salus Group
  • 185. SANTA Pharm
  • 186. Santen Pharmaceutical
  • 187. Schluter Print Pharma Packaging (acquired by WestRock)
  • 188. SCHOTT
  • 189. Selig Flexibles
  • 190. Sentry BioPharma Services
  • 191. Sepha
  • 192. Seveillar Clinical Supplies
  • 193. SGD Pharma
  • 194. Sharp
  • 195. Sherpa Clinical Packaging (acquired by PCI Pharma Services)
  • 196. Singota Solutions
  • 197. SkyePharma
  • 198. Smurfit Kappa
  • 199. Sonoco
  • 200. Spectrum Pharma
  • 201. SteriPack
  • 202. Stevanato Group
  • 203. Supply Chain Wizard
  • 204. Suzuken
  • 205. Swiftpak
  • 206. SYNERLAB Group
  • 207. Syntegon
  • 208. Takeda Pharmaceutical
  • 209. Tapemark
  • 210. Tenco Assemblies
  • 211. Teva-Takeda Pharmaceuticals
  • 212. The FlexPro Group
  • 213. Therabel
  • 214. Tjoapack
  • 215. Total Health Centre
  • 216. TriRx Pharmaceutical Services
  • 217. TT-print (acquired by Constantia Flexibles)
  • 218. Unette
  • 219. Unither Pharmaceuticals
  • 220. Veratrak
  • 221. Verpak Ambalaj
  • 222. Vetter Pharma
  • 223. Vihaa Print And Pack
  • 224. Voigt Industrie Service
  • 225. Wasdell Group
  • 226. West Pharmaceutical Services
  • 227. WestRock
  • 228. Wuxi Griffin
  • 229. Xellia Pharmaceuticals
  • 230. Xerimis
  • 231. Yourway
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!